SCHEMBL739975

SCHEMBL739975

COCCCn1c([C@@H]2CCCN(C(=O)C[C@H](N)Cc3cccnc3)C2)nc2ccccc21

nearest known ligand 0.45

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.45
KCNH2 Q12809 10/20 0.44
HRH1 P35367 11/20 0.43
CYP2D6 P10635 7/20 0.43
CHRM1 P11229 3/20 0.43
USP2 O75604 1/20 0.40
POLB P06746 1/20 0.40
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL739976 1.00 DPP4 (0.45) DPP4KCNH2HRH1CYP2D6CHRM1
SCHEMBL740634 0.92 HRH1 (0.49) KCNH2HRH1CYP2D6CHRM1USP2
SCHEMBL739450 0.92 HRH1 (0.49) KCNH2HRH1CYP2D6CHRM1USP2
SCHEMBL740944 0.92 HRH1 (0.42) KCNH2HRH1CYP2D6CHRM1CYP3A4
SCHEMBL741802 0.92 HRH1 (0.42) KCNH2HRH1CYP2D6CHRM1CYP3A4
SCHEMBL739543 0.92 HRH1 (0.47) DPP4KCNH2HRH1CYP2D6CHRM1
SCHEMBL739542 0.92 HRH1 (0.47) DPP4KCNH2HRH1CYP2D6CHRM1
SCHEMBL740155 0.89 HRH1 (0.45) KCNH2HRH1CYP2D6CHRM1USP2
SCHEMBL740154 0.89 HRH1 (0.45) KCNH2HRH1CYP2D6CHRM1USP2
SCHEMBL738945 0.88 HRH1 (0.45) KCNH2HRH1CYP2D6CHRM1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138168-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-20 US claimed
US-8138168-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-20 US disclosed
US-8138168-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-20 US disclosed
US-8138168-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-20 US disclosed